MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 49 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 4.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,604 | +69.3% | 17,293 | +55.6% | 0.00% | – |
| Q2 2023 | $31,668 | -20.4% | 11,113 | +10.1% | 0.00% | – |
| Q1 2023 | $39,779 | +261.6% | 10,097 | +250.0% | 0.00% | – |
| Q4 2022 | $11,000 | -54.2% | 2,885 | +10.9% | 0.00% | – |
| Q3 2022 | $24,000 | +33.3% | 2,602 | -9.6% | 0.00% | – |
| Q2 2022 | $18,000 | 0.0% | 2,879 | 0.0% | 0.00% | – |
| Q1 2022 | $18,000 | +5.9% | 2,879 | +14.2% | 0.00% | – |
| Q4 2021 | $17,000 | +70.0% | 2,520 | +39.1% | 0.00% | – |
| Q3 2021 | $10,000 | +25.0% | 1,811 | +23.0% | 0.00% | – |
| Q2 2021 | $8,000 | +166.7% | 1,472 | +144.9% | 0.00% | – |
| Q1 2021 | $3,000 | – | 601 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 2,066,529 | $38,541,000 | 23.79% |
| Novo Holdings A/S | 2,674,470 | $49,879,000 | 8.54% |
| ACUTA CAPITAL PARTNERS, LLC | 369,500 | $6,891,000 | 4.97% |
| RTW INVESTMENTS, LP | 3,521,856 | $63,819,000 | 3.80% |
| Boxer Capital, LLC | 1,102,194 | $20,556,000 | 1.49% |
| Ghost Tree Capital, LLC | 235,000 | $4,383,000 | 1.12% |
| VHCP Management II, LLC | 148,560 | $2,771,000 | 1.06% |
| Tekla Capital Management LLC | 46,940 | $812,000 | 0.04% |
| Baker Brothers Advisors | 266,667 | $4,973,000 | 0.03% |
| Zimmer Partners, LP | 160,000 | $2,984,000 | 0.03% |